Company profile for SmartPharm Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SmartPharm Therapeutics Inc. is a privately held, pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of serious or rare diseases with the vision of creating “Biologics from Within.” SmartPharm is currently developing a novel pipeline of non-viral, gene-encoded proteins for the treatment of conditions that require biologic therapy such as enzyme replacement and tissue re...
SmartPharm Therapeutics Inc. is a privately held, pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of serious or rare diseases with the vision of creating “Biologics from Within.” SmartPharm is currently developing a novel pipeline of non-viral, gene-encoded proteins for the treatment of conditions that require biologic therapy such as enzyme replacement and tissue restoration.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
c/o LabCentral, 700 Main Street, North Cambridge, MA 02139-3543
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Product Expo West

Natural Product Expo West

Not Confirmed

envelop Contact Supplier

Natural Product Expo West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2020/09/02/2087762/0/en/Sorrento-Announces-the-Closing-of-Its-Acquisition-of-SmartPharm-to-Build-Next-Generation-G-MAB-Encoded-Plasmid-DNA-For-Cost-Efficient-and-In-Vivo-Production-of-Antibody-Therapeutic.html

GLOBENEWSWIRE
02 Sep 2020

http://www.globenewswire.com/news-release/2020/08/20/2081668/0/en/Sorrento-Enters-Into-Merger-Agreement-to-Acquire-SmartPharm-and-Develop-Pipeline-of-Gene-Encoded-Therapeutic-Antibodies-Starting-With-Neutralizing-Antibodies-to-Treat-COVID-19-and-.html

GLOBENEWSWIRE
20 Aug 2020

https://www.prnewswire.com/news-releases/sorrento-enters-into-letter-of-intent-to-acquire-smartpharm-and-develop-pipeline-of-gene-encoded-therapeutic-antibodies-starting-with-neutralizing-antibodies-to-treat-covid-19-and-cancer-therapeutics-301099317.html

PRNEWSWIRE
24 Jul 2020

https://pipelinereview.com/index.php/2020032374082/DNA-RNA-and-Cells/Sorrento-and-Smartpharm-to-collaborate-to-develop-novel-gene-encoded-antibody-vaccine-intended-to-protect-against-COVID-19.html

PIPELINEREVIEW
23 Mar 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty